Robert M. OʼBryan - Concepedia

Author

Robert M. OʼBryan

Also Known As

R M O'Bryan, R O'Bryan, R. M. O'Bryan, R. M. O’Bryan, R. M. O’bryan, ROBERT M. O'BRYAN, Robert M O'Bryan, Robert M. O'Bryan, Robert M. O'bryan, Robert M. OʼBryan

Publications

Citations

H-Index

Concepts

All Affiliations

Henry Ford Hospital SWOG Cancer Research Network University of Kansas Medical Center University of Utah University of Arkansas for Medical Sciences

About

Robert M. OʼBryan is an author at Henry Ford Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	183
2	Health Sciences	2	2	92
3	Nursing	1	1	14
4	Endocrinology	1	1	18
5	Immunology	1	1	28

Robert M. OʼBryan

Publications

974

Citations

H-Index

Page 1

	Year	Citations
Phase II evaluation of adriamycin in human neoplasia Robert M. OʼBryan, James K. Luce, Robert W. Talley, Cancer	1973	415
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Jeffrey A. Gottlieb, Robert S. Benjamin, Laurence H. Baker, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)	1976	141
Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest oncology group study Ronald M. Bukowski, Stanley P. Balcerzak, Robert M. OʼBryan, Cancer	1983	79
Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma.A southwest cancer chemotherapy study group study Jeffrey A. Gottlieb, Saul E. Rivkin, Stuart C. Spigel, Cancer Breast OncologyCancer ManagementOral NitrosoureasPharmacotherapyMetronomic Chemotherapy	1974	64
Causes for The Undertreatment of Elderly Breast Cancer Patients: Tailoring Treatments To Individual Patients Vic Velanovich, Molly Gabel, Eleanor Walker, Journal of the American College of Surgeons	2002	64
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma Robert G. Gagliano, Howard S. Levin, M. N. El‐Bolkainy, American Journal of Clinical Oncology	1983	48
Predictors of survival following relapse or progression of small cell lung cancer. Southwest oncology group study 8605 report and analysis of recurrent disease data base Kathy S. Albain, John J. Crowley, Laura F. Hutchins, Cancer	1993	44
Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery Harmon J. Eyre, Joseph M. Quagliana, James R. Eltringham, Journal of Neuro-Oncology Neuro-oncologySurgical OncologyRadiation TherapyGliomaCcnu Versus Radiotherapy	1983	44
Combination chemotherapy plus levamisole in the treatment of disseminated malignant melanoma a southwest oncology group study John J. Costanzi, William S. Fletcher, Stanley P. Balcerzak, Cancer Surgical OncologyDisseminated Malignant MelanomaImmunologyDermatologyImmunotherapy	1984	28
Congenital Adrenocortical Hyperplasia With Cushing's Syndrome Robert M. OʼBryan, Richmond W. Smith, Gerald Fine, JAMA Adrenal GlandGeneralized WastingPituitary GlandFatal CaseAdrenal Health	1964	18

Page 1